- Home
- KROS vs NPKI Comparison
KROS vs NPKI Comparison
Compare KROS & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NPKI
- Stock Information
- Founded
- KROS 2015
- NPKI 1932
- Country
- KROS United States
- NPKI United States
- Employees
- KROS N/A
- NPKI N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NPKI Metal Fabrications
- Sector
- KROS Health Care
- NPKI Industrials
- Exchange
- KROS Nasdaq
- NPKI Nasdaq
- Market Cap
- KROS 589.8M
- NPKI 665.2M
- IPO Year
- KROS 2020
- NPKI N/A
- Fundamental
- Price
- KROS $11.84
- NPKI $7.67
- Analyst Decision
- KROS Buy
- NPKI
- Analyst Count
- KROS 11
- NPKI 0
- Target Price
- KROS $45.33
- NPKI N/A
- AVG Volume (30 Days)
- KROS 2.1M
- NPKI 363.4K
- Earning Date
- KROS 02-26-2025
- NPKI 02-19-2025
- Dividend Yield
- KROS N/A
- NPKI N/A
- EPS Growth
- KROS N/A
- NPKI N/A
- EPS
- KROS N/A
- NPKI N/A
- Revenue
- KROS $651,000.00
- NPKI $748,372,000.00
- Revenue This Year
- KROS $303.27
- NPKI N/A
- Revenue Next Year
- KROS N/A
- NPKI N/A
- P/E Ratio
- KROS N/A
- NPKI N/A
- Revenue Growth
- KROS 8037.50
- NPKI 93.70
- 52 Week Low
- KROS $9.78
- NPKI $5.61
- 52 Week High
- KROS $73.00
- NPKI $8.65
- Technical
- Relative Strength Index (RSI)
- KROS 24.87
- NPKI N/A
- Support Level
- KROS $10.95
- NPKI N/A
- Resistance Level
- KROS $11.63
- NPKI N/A
- Average True Range (ATR)
- KROS 0.87
- NPKI 0.00
- MACD
- KROS 1.31
- NPKI 0.00
- Stochastic Oscillator
- KROS 30.60
- NPKI 0.00
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NPKI NPK International Inc. Common Stock
NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.